Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation.
Design and in vitro/in vivo evaluation of extended release matrix tablets of
nateglinide. J Young Pharm.
The drugs were categorized into 5 distinct groups: metformin, glyburide, thiazolidinediones (pioglitazone, rosiglitazone), insulin and other oral hypoglycemic agents (chlorpropamide, gliclazide, tolbutamide, glimepiride, sitagliptin, saxagliptin,
nateglinide, repaglinide).
Nateglinide, a derivative of meglitinide, is an oral antidiabetic drug used for the treatment of type II diabetes mellitus.
Zhang et al., "
Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in Chinese antihyperglycemic agent-naive subjects with type 2 diabetes," Diabetes Technology & Therapeutics, vol.
These include sulfonylureas, such as glipizide and glimepiride, and glinides, such as repaglinide (Prandin) and
nateglinide (Starlix).
Nateglinide (Starlix) and repaglinide (Prandin) are the agents in this subclass.
Nateglinide (Starlix[R]) Thiazolidinediones Rosiglitazone Reduces production of (Avadia[R]) glucose by liver.
Meglitinides (e.g.,
nateglinide [Starlix[R]], repaglinide [Prandin[R]]) increase insulin secretion by a similar mechanism as sulfonylureas, with similar efficacy in reducing HbA1c (Bennett et al., 2011).